Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?
Second-line chemotherapy for hormone-refractory prostate cancer: has the time come? Clin Prostate Cancer. 2004 Sep; 3(2):122-4.
View in:
PubMed
subject areas
Aged
Androgen Antagonists
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
Humans
Male
Middle Aged
Mitoxantrone
Neoadjuvant Therapy
Neoplasm Staging
Prognosis
Prostate-Specific Antigen
Prostatic Neoplasms
Randomized Controlled Trials as Topic
Risk Assessment
Survival Analysis
Taxoids
Treatment Outcome